NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
35 hedge funds and large institutions have $8.63M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
35
Holding in Top 10
1
Calls
$66K
Puts
–
Top Buyers
| 1 | +$75K | |
| 2 | +$64.5K | |
| 3 | +$7.34K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.43K |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.08K |
Top Sellers
| 1 | -$615K | |
| 2 | -$447K | |
| 3 | -$45.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42K |
| 5 |
VF
Virtu Financial
New York
|
-$25K |